Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This is a phase I/II study of the combination of etanercept and rituximab in patients with
chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). This combination is
proposed to improve the efficacy and diminish the toxicity of this the
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
John Byrd Ohio State University Comprehensive Cancer Center